PLX PHARMA INC (PLXP) Stock Balance Sheet
NASDAQ:PLXP - Nasdaq - US72942A1079 - Common Stock - Currency: USD
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 25.83M | 69.39M | 22.45M | 14.00M | 14.25M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 139.00K | 634.00K | 0.00 | 20.00K | 20.00K | |||
| Inventories | 3.18M | 2.46M | 140.00K | N/A | 0.00 | |||
| Other Current Assets | 1.07M | 992.00K | 390.00K | 260.00K | 600.00K | |||
| Total Current Assets | 30.22M | 73.48M | 22.99M | 14.28M | 14.87M | |||
| Non-Current Assets | ||||||||
| PPE Net | 968.00K | 1.09M | 1.55M | 2.08M | 1.39M | |||
| Goodwill | 2.06M | 2.06M | 2.06M | 2.06M | 2.06M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | -26.00K | 17.00K | 20.00K | 70.00K | 70.00K | |||
| Total Non-Current Assets | 3.00M | 3.17M | 3.63M | 4.22M | 3.52M | |||
| TOTAL ASSETS | 33.22M | 76.64M | 26.62M | 18.50M | 18.39M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 620.00K | 3.66M | 2.91M | |||
| Accrued Expenses | 1.24M | 1.28M | 2.02M | 1.51M | 1.17M | |||
| Accounts Payable | 5.07M | 10.60M | 860.00K | 930.00K | 650.00K | |||
| Other Current Liabilities | 5.32K | 1.00K | 30.00K | N/A | N/A | |||
| Total Current Liabilities | 6.31M | 11.88M | 3.54M | 6.09M | 4.73M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 620.00K | 4.28M | |||
| Other Non-Current Liabilities | 711.00K | 13.08M | 12.62M | 10.22M | 2.93M | |||
| Total Non-Current Liabilities | 711.00K | 13.08M | 12.62M | 10.84M | 7.21M | |||
| TOTAL LIABILITIES | 7.02M | 24.96M | 16.16M | 16.93M | 11.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -179.41M | -148.27M | -102.15M | -86.94M | -66.44M | |||
| Additional Paid In Capital | 189.57M | 183.91M | 91.20M | 74.84M | 72.87M | |||
| Common Shares | 16.04M | 16.04M | 21.39M | 13.67M | 10.00K | |||
| Shares Outstanding | 29.14M | 27.54M | 13.91M | 9.16M | 8.74M | |||
| Tangible Book Value per Share | 0.28 | 1.22 | -0.93 | -1.54 | 0.50 | |||
| Total Shareholders' Equity | 26.20M | 51.68M | 10.45M | 1.57M | 6.44M | |||
| TOTAL LIABILITIES AND EQUITY | 33.22M | 76.64M | 26.62M | 18.50M | 18.39M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.39 | 0.66 | |||
| Current Ratio | 4.79 | 6.19 | 6.49 | 2.34 | 3.14 | |||
| Return On Assets (ROA) | -83.01% | -63.48% | -63.67% | -185.14% | 4.89% | |||
| Return On Equity (ROE) | -105.25% | -94.14% | -162.20% | -2181.53% | 13.98% | |||
All data in USD , ROIC based on taxRate of 0.21